Armistice Capital, LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:01 pm Sale | 2024-09-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Armistice Capital, LLC | 0 0.000% | -5,200,000 (Position Closed) | Filing |
| 2024-02-14 2:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Armistice Capital, LLC | 5,200,000 6.490% | 28,000 (+0.54%) | Filing |
| 2023-02-14 12:32 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Armistice Capital, LLC | 5,172,000 7.650% | 1,741,846 (+50.78%) | Filing |
| 2022-02-14 6:35 pm Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Armistice Capital, LLC | 3,430,154 5.900% | 3,430,154 (New Position) | Filing |